Parisa Gazerani | OMICS International
ISSN: 2167-0846

Journal of Pain & Relief
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Parisa Gazerani

Parisa Gazerani -Associate Professor, The Faculty of Medicine, Department of Health Science and Technology, Biomedicine Group, Center for Sensory-Motor Interaction, Center for Neuroplasticity and Pain, Integrative Neuroscience Laboratory for Cancer Biology.


Parisa Gazerani is awarded PhD in Pain, Neuropharmacology from Aalborg Universitet, and Denmark in the year 2006. Currently, she is working as an Associate Professor for Aalborg UniversityIBRO Committee on Women in World Neuroscience.She has extended her valuable service in Western Europe regional liaison IBRO Committee on Women in World Neuroscience from 2008 – Present (8 years); she was Research assistant in Aalborg university from2006 – 2007 and has been a recipient of many award and grants. Her international experience includes various programs, contributions and participation in different countries for diverse fields of study. Her research interests reflect in her wide range of publications in Aalborg university Research portal. She is the Editorial Board Member of Simulated airplane headache: a proxy towards identification of underlying mechanisms and serves as a member of various associations 


Research Interest

Basic Pharmacology, Clinical Pharmacology, Translational Medicine, Neuroscience Pain. Her Research Have been in- Interaction between ultraviolet B-induced cutaneous hyperalgesia and nerve growth factor-induced muscle hyperalgesia. Adenosine A3 receptor agonists: do recent findings offer new hope in chronic pain treatment? A human surrogate model of itch utilizing the TRPA1 agonist trans-cinnamaldehyde


Global Speakers in the subject

Global Experts in the subject